European Heart Journal - Cardiovascular Pharmacotherapy

eISSN: 2055-6845pISSN: 2055-6837

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
7.8
H-Index
35
Impact Factor
5 - 10
SJR
Q1Pharmacology (medical)
SNIP
1.61
2
Time to Publish
time-to-publish View Chart
2  Mo

Journal Specifications

Overview
  • Publisher
    OXFORD UNIV PRESS
  • Language
    English
  • Frequency
    Bi-monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 76%
4-6 22%
7-9 2%
>9 0%

Topics Covered

Myocardial infarction
Kidney disease
Atrial fibrillation
Aspirin
Heart failure
Confidence interval
Rivaroxaban
Colchicine
Percutaneous coronary intervention
Cardiovascular outcomes
Major bleeding
Anticoagulant
Ticagrelor
Apixaban
Pooled analysis
Blood pressure
Nonsteroidal
Liver disease
Ejection fraction
Hazard ratio

Recently Published Papers

Year-wise Publication

FAQs

Since when has European Heart Journal - Cardiovascular Pharmacotherapy been publishing? Faqs

The European Heart Journal - Cardiovascular Pharmacotherapy has been publishing since 2015 till date.

How frequently is the European Heart Journal - Cardiovascular Pharmacotherapy published? Faqs

European Heart Journal - Cardiovascular Pharmacotherapy is published Bi-monthly.

What is the H-index. SNIP score, Citescore and SJR of European Heart Journal - Cardiovascular Pharmacotherapy? Faqs

European Heart Journal - Cardiovascular Pharmacotherapy has a H-index score of 35, Citescore of 7.8, SNIP score of 1.61, & SJR of Q1

Who is the publisher of European Heart Journal - Cardiovascular Pharmacotherapy? Faqs

The publisher of European Heart Journal - Cardiovascular Pharmacotherapy is OXFORD UNIV PRESS.

How can I view the journal metrics of European Heart Journal - Cardiovascular Pharmacotherapy on editage? Faqs

For the European Heart Journal - Cardiovascular Pharmacotherapy metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of European Heart Journal - Cardiovascular Pharmacotherapy? Faqs

The eISSN number is 2055-6845 and pISSN number is 2055-6837 for European Heart Journal - Cardiovascular Pharmacotherapy.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Myocardial infarction, Kidney disease, Atrial fibrillation, Aspirin, Heart failure, Confidence interval, Rivaroxaban, Colchicine, Percutaneous coronary intervention, Cardiovascular outcomes, Major bleeding, Anticoagulant, Ticagrelor, Apixaban, Pooled analysis, Blood pressure, Nonsteroidal, Liver disease, Ejection fraction, Hazard ratio.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.